The Latest Biotechnology / Pharmaceuticals Articles from Streetwise Reports


This Pharmaceutical Company Has a Brilliant Concept

  ()
Algernon Pharmaceutical is a clinical-stage, small biotech that boasts a massive pipeline of lower risk and efficient drugs. The company currently has a market cap of US$11.25M, $2M cash in the bank, and several promising late-stage drugs — and it is bound for the NASDAQ. Its closest competitors working on similar illnesses and at similar stages have market caps between $91 and $660 million. Catalysts abound with this genius repurposing company.
Tags:  Biotechnology / Pharmaceuticals

Ph1 Trial Results of Dementia Drug Positive

Research Report
  ()
Anavex Life Sciences' study of Anavex 3-71 in frontotemporal dementia met primary and secondary safety endpoints, noted a Dawson James Securities report.
Tags:  Biotechnology / Pharmaceuticals

Biotech Co. Partners With Life Sciences Firms

Research Report
  ()
2seventy entered agreements with Novo Nordisk and Genevant to get an in vivo gene editing treatment for hemophilia A developed, noted a Wedbush report.
Tags:  Biotechnology / Pharmaceuticals

Enrollment Done for COVID-19 Drug Trial

Research Report
  ()
Part 2 of First Wave BioPharma's RESERVOIR trial of niclosamide to remove the SARS-CoV-2 virus from the GI tract is underway, noted a ROTH Capital Partners report.
Tags:  Biotechnology / Pharmaceuticals

2022 to Be Catalyst Rich for Biopharma

Research Report
  ()
The potential stock-moving events for Infinity Pharmaceuticals this year include the launch of two clinical trials and readouts from four studies, noted an H.C. Wainwright & Co. report.
Tags:  Biotechnology / Pharmaceuticals

Co.'s samRNA Vaccines Protect Better Against COVID Variants

Research Report
  ()
Gritstone bio Inc.'s lower-dose samRNA vaccines include a broader immune response to SARS-CoV-2 and may provide better protection against emerging variants. BTIG research has issued a "Buy" rating for Gritstone bio.
Tags:  Biotechnology / Pharmaceuticals

AI Driven Drug Firm Partners With Merck

  ()
Shares of Absci Corp. rose 18% after the company reported it is collaborating with Merck & Co. to create enzymes using its deep-learning Integrated Drug Creation™ platform and Bionic Protein™ technologies.
Tags:  Biotechnology / Pharmaceuticals

Co. Partners to Test New Cancer Vaccines

Research Report
  ()
Genocea Biosciences Inc. is teaming up with Janssen Biotech to explore the immunogenicity of neoantigens and the role and impact of Inhibigens™ in potential vaccine therapies for cancer. H.C. Wainwright & Co. advised that it currently has a "Buy" rating on Genocea.
Tags:  Biotechnology / Pharmaceuticals

Co. Plans to Make 100M Rapid COVID Tests Monthly

Research Report
  ()
Biopharmaceutical firm Sorrento Therapeutics Inc. plans to mobilize a fully automated assembly line in San Diego, Calif., capable of producing 6 million rapid antigen detection COVISTIX testing units per month starting in Q1/22.
Tags:  Biotechnology / Pharmaceuticals

New Muscular Dystrophy Drug Shows Promise

  ()
Edgewise Therapeutics shares traded 24% higher after the company reported its EDG-5506 significantly lowered muscle damage biomarkers in adults after just two weeks of dosing in its Becker muscular dystrophy trial.
Tags:  Biotechnology / Pharmaceuticals

Chen Lin's Top 6 Investment Ideas

  ()
In a recent interview with Streetwise Reports, family assets manager and contributing writer, Chen Lin, shared the six (mostly mid-cap) companies that are his top investment picks for 2022.
Tags:  GoldBiotechnology / Pharmaceuticals

Lead Cancer Drug Gets Fast Tracked

  ()
Shares of Genprex Inc. traded 165% higher after the company reported the U.S. FDA has awarded Fast Track Designation for its REQORSA™ Immunogene Therapy for use in combination with Merck & Co.'s Keytruda® for non-small cell lung cancer treatment.
Tags:  Biotechnology / Pharmaceuticals

Analyst: Drug a 'Hidden Gem for 2022'

Research Report
  ()
Oppenheimer ranks Astria Therapeutics Outperform after learning about its drug for hereditary angioedema, saying "We stay bullish."
Tags:  Biotechnology / Pharmaceuticals

Co. Still Compelling After Drug Trial Failure

Research Report
  ()
"Arcalyst remains the value driver" for Kiniksa Pharmaceuticals, and "we continue to hold a favorable view of the company," noted a Wedbush report.
Tags:  Biotechnology / Pharmaceuticals

Co. Looks To US For Help Fighting Strokes

  ()
Canadian company Algernon Pharmaceuticals Inc. has applied to uplist to the Nasdaq in hopes of attracting U.S. investors to its mission to repurpose drugs.
Tags:  Biotechnology / Pharmaceuticals

Co. Rated Outperform As Heart Failure Drug Nears Potential Approval

Research Report
  ()
"Cytokinetics' pipeline of muscle-directed therapies has potential to address several diseases with high unmet medical need and may generate significant revenue across pipeline programs," noted an Oppenheimer report.
Tags:  Biotechnology / Pharmaceuticals

Analyst: Question Lingers Over Biotech’s Cell Therapy

Research Report
  ()
A DawsonJames report notes that Brainstorm Cell Therapeutics’ autologous stem cells in amyotrophic lateral sclerosis will need further study to prove their effectiveness.
Tags:  Biotechnology / Pharmaceuticals

Coverage Initiated on Biopharma Co. After Turnaround Story

Research Report
  ()
"With Acasti Pharma shares trading near cash levels yet current resources sufficient to achieve key development milestones across the pipeline over 2022-2023, we recommend investors build a position," noted an Oppenheimer report.
Tags:  Biotechnology / Pharmaceuticals

Analyst Highlights Top Picks in Biotech for 2022

Research Report
  ()
Aldeyra Therapeutics, in the ophthalmology space, and SQZ Biotechnologies, in the cell therapy sector, have "advantages that their specific approaches allow," noted a BTIG report.
Tags:  Biotechnology / Pharmaceuticals

FDA Grants Approval for CNS-Focused Biopharma Firm's Bipolar Disorder Drug

  ()
Intra-Cellular Therapies Inc. shares traded 19% higher to a new 52-week high after the company reported the U.S. FDA has approved the use of its CAPLYTA® (lumateperone) for treatment of adults with bipolar depression.
Tags:  Biotechnology / Pharmaceuticals

Co. Launches Pivotal Phase in Alzheimer's Agitation Drug's Trial

Research Report
  ()
BioXcel Therapeutics' lead drug candidate for agitation in Alzheimer's disease patients could serve a substantial market, noted an H.C. Wainwright & Co. report.
Tags:  Biotechnology / Pharmaceuticals

Analyst Says Regeneron Could Be 'Biotech Champion'

Research Report
  ()
Regeneron Pharmaceuticals Inc.'s stock was up 36% in 2021 while the NASDAQ Biotechnology Index remained flat, Oppenheimer analyst Hartaj Singh reported in a Dec. 16 research note.
Tags:  Biotechnology / Pharmaceuticals

Co.'s Shares Gain 27% After FDA Nears Drug Approval

  ()
Shares of Calliditas Therapeutics AB traded higher after the company reported the U.S. FDA granted accelerated approval for its TARPEYO™ (budesonide) to reduce proteinuria in IgA nephropathy.
Tags:  Biotechnology / Pharmaceuticals

Target Price Raised on Biotech Based on Management Update

Research Report
  ()
During its recent R&D Day, Prometheus Biosciences announced new strong trial data, another new indication for its lead therapeutic candidate and progress in developing a subcutaneous formulation of it, according to an Oppenheimer report.
Tags:  Biotechnology / Pharmaceuticals

Showing Results: 1 to 25 of 112 Next

Get Our Streetwise Reports Newsletter Free and be the first to know!

A valid email address is required to subscribe

More Experts

"There are good reasons to believe OMM stock is at a bottom." ❭
– Clive Maund, CliveMaund.com
"I used the mill commissioning delay to add some positions in MAG." ❭
– Chen Lin, What Is Chen Buying? What Is Chen Selling?
"KLD stock is now forming a bull flag that will lead to another upleg." ❭
– Clive Maund, CliveMaund.com
"POE is generating $2M+ pretax cash flow every month." ❭
– Chen Lin, What Is Chen Buying? What Is Chen Selling?
"CBR is well financed for its entire 25,000m drill program." ❭
– Bob Moriarty, 321 Gold